PRONTO-EYE for Diabetic Retinopathy
(PRONTO-EYE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called PRONTO-EYE, which provides free rides to help people reach their eye doctor appointments. The goal is to determine if transportation improves attendance for patients with diabetic retinopathy (eye damage from diabetes) at their scheduled visits. The trial specifically targets Medicaid patients with this eye condition. Candidates may qualify if they have diabetic retinopathy, Medicaid insurance, and live within 25 miles of the clinic. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance access to essential eye care.
What prior data suggests that the PRONTO-EYE rideshare intervention is safe for patients with diabetic retinopathy?
Research has shown that the PRONTO-EYE program offers a new way to help people with diabetic retinopathy maintain their eye care visits. This program provides free rides to appointments, focusing solely on transportation without involving any medical treatment. As a result, it poses no health risks or side effects like those associated with medicines or surgeries.
Studies have found that transportation problems often cause people to miss medical visits. By offering free rides, PRONTO-EYE aims to address this issue. The primary goal is to facilitate access to appointments, not to provide a drug or medical procedure. Consequently, there is no evidence of any health risks from this program.12345Why are researchers excited about this trial?
Unlike traditional treatments for diabetic retinopathy that focus on medical or surgical interventions, PRONTO-EYE introduces a novel approach by addressing transportation barriers. This rideshare program is designed to improve patient adherence to eye care visits, which is crucial for effective management of the condition. Researchers are excited about this trial because it explores how improving access to healthcare services can enhance treatment outcomes, potentially offering a scalable solution to increase patient attendance and compliance.
What evidence suggests that the PRONTO-EYE rideshare program is effective for improving adherence to eye care visits in patients with diabetic retinopathy?
Research shows that transportation issues can hinder patients from attending medical appointments. Studies have found that offering rideshare services helps patients maintain their medical visits. In this trial, all eligible patients are invited to participate in PRONTO-EYE, a rideshare transportation program designed to improve adherence to eye care visits among Medicaid patients with diabetic retinopathy. Early results suggest that transportation programs like PRONTO-EYE may help more patients attend their eye care appointments. This is important because regular eye exams are key to managing diabetic retinopathy and preventing vision loss. While data is still being gathered on PRONTO-EYE's direct impact on diabetic retinopathy outcomes, similar programs have shown promise.12367
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention Implementation
Implementation of the PRONTO-EYE rideshare transportation program to improve adherence to eye care visits
Follow-up
Participants are monitored for adherence to scheduled ophthalmology visits and secondary implementation outcomes
What Are the Treatments Tested in This Trial?
Interventions
- PRONTO-EYE
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
All eligible patients are invited to participate in PRONTO-EYE, a rideshare transportation program designed to improve adherence to eye care visits among Medicaid patients with diabetic retinopathy. All eligible patients are included in this arm regardless of if they decide to use PRONTO-EYE or not.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
National Eye Institute (NEI)
Collaborator
Citations
NCT07296952 | Using Implementation Science to Adapt a ...
This is a a type 3 hybrid effectiveness-implementation pilot study to evaluate the PRONTO-EYE intervention, a rideshare transportation program, in patients with ...
Toward equity in vision health: Using human-centered design ...
... rideshare transportation program for patients with diabetic retinopathy (PRONTO-EYE) ... outcomes. This abstract was presented at the 2025 ARVO Annual ...
Experiment-Based Interventions to Diabetic Retinopathy - PMC
This review also summarizes novel therapeutic attempts for diabetic retinopathy along with their advantages and disadvantages.
4.
retina-specialist.com
retina-specialist.com/article/clinical-trial-lessons-for-managing-diabetic-retinopathyClinical trial lessons for managing diabetic retinopathy
Key clinical trials can help us determine how to individualize treatment plans for patients with diabetic retinopathy.
Diabetic Retinopathy Clinical Research Trials
Investigators plan to conduct a type 3 hybrid effectiveness-implementation pilot study using a pre-post intervention design to evaluate the PRONTO-EYE ...
Report From the NEI/FDA Diabetic Retinopathy Clinical Trial ...
Sun presented a case example of an eye with severe NPDR that received ranibizumab and showed a three-step improvement of DR severity after 36 months of ...
Evaluation of Intravitreal Aflibercept for the Treatment ...
The Diabetic Retinopathy Study found that untreated eyes with PDR have a 37% rate of severe vision loss at 72 months, and a patient who does not ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.